Anonymous ID: b73875 April 7, 2020, 9:33 a.m. No.8713850   🗄️.is đź”—kun   >>4059

>>8713628

What's in your bottle water?

Who filled it?

Do you trust them?

Do you even know them?

Who tested your bottle water?

Did the test the whole pallet, or one bottle?

What is the USPHS responsible for?

Who governs our food?

Who governs our drugs?

Same people who govern our water?

Think bottling companies

Who knows the recipes for Coke?

Who knows the recipes for "Jesuit's Bark"?

Who profits off of every bottle of everything sold regardless of content?

How does one choose one BRAND over another?

The packaging?

The bottle?

The label?

The price?

The contents?

Are ingredients listed in bottled tap water?

 

https://law.resource.org/pub/us/cfr/ibr/006/usphs.956.1962.pdf

Anonymous ID: b73875 April 7, 2020, 9:51 a.m. No.8713985   🗄️.is đź”—kun

Call for help digging

 

The NIH is the parent org of Fauci's outfit, NIAID.

 

I cannot find exactly how they are linked though. No org charts or anything actually connect the two agencies.

 

Also, check out the "Old NIH" logo next to the NIAID logo!!!

 

I think this is Fauci's boss at NIH, but I''m not sure. They all work for Azar at HHS.

 

NIH Director Francis S. Collins, M.D., Ph.D.

Portrait of Dr. Francis Collins

Dr. Francis Collins

Francis S. Collins, M.D., Ph.D., was appointed the 16th Director of the National Institutes of Health by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. On June 6, 2017, President Donald Trump announced his selection of Dr. Collins to continue to serve as the NIH Director. He is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the Human Genome Project, served as Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health from 1993-2008. Read Dr. Collins’ bio sketch.

Anonymous ID: b73875 April 7, 2020, 10 a.m. No.8714059   🗄️.is đź”—kun

>>8713850

 

Who are you trusting to keep your drinking water safe and clean?

 

ADM Brett P. Giroir, M.D.

Assistant Secretary for Health (ASH)

HHS Office of the Secretary

 

ADM Brett P. Giroir, M.D., was sworn in as the 16th Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) on February 15, 2018. As the Assistant Secretary for Health (ASH), Admiral (ADM) Brett P. Giroir oversees the USPHS Commissioned Corps, providing it with strategic and policy direction. The Assistant Secretary for Health leads development of HHS-wide public health policy recommendations and oversees several of the Department’s core public health offices — including the Office of the Surgeon General. His office leads many critical national initiatives, including an historic new plan to end the HIV Epidemic in America, the Physical Activity Guidelines for Americans, the revised Common Rule and a cross-agency effort to improve the outcomes of patients living with sickle cell disease.

 

In addition, ADM Giroir serves as Senior Adviser to the Secretary for Opioid Policy, responsible for coordinating HHS’s efforts across the Administration to fight America's opioid crisis.

 

ADM Giroir is a pediatric critical care specialist and physician-scientist, who has served in a number of leadership positions in the federal government as well as academia.

 

He was executive vice president and CEO of Texas A&M's Health Science Center from 2013-2015, and professor of pediatrics and engineering, having earlier served as vice chancellor of strategic initiatives (2011-2013) and vice chancellor for research (2008-2011) for the Texas A&M University system. Prior, he was professor of pediatrics and endowed chair at the University of Texas Southwestern Medical Center from 1993-2003, and was the first chief medical officer of Children's Medical Center of Dallas (now Children's Health).

 

ADM Giroir’s federal service includes directing the Defense Sciences Office of the Defense Advanced Research Projects Agency (DARPA) from 2006-2008. He joined the office in 2004 as deputy director, and also served on the Department of Defense’s Threat Reduction Advisory Committee both during his tenure at DARPA and thereafter. From 2014-2015, he chaired the Veteran’s Choice Act Blue Ribbon Panel to reform the U.S. Veterans Health System.

 

ADM Giroir has authored or co-authored more than 100 scientific publications, editorials and book chapters. He is the recipient of numerous honors and awards, including the U.S. Secretary of Defense Medal for Outstanding Public Service, the American Heart Association’s President Lyndon Baines Johnson Research Award, and the American Society of Nephrology’s President’s Medal. ADM Giroir was the nation’s high school debate champion in 1978. He received a bachelor’s degree in biology, magna cum laude, from Harvard University, and a medical degree from the University of Texas Southwestern Medical Center.

Anonymous ID: b73875 April 7, 2020, 10:27 a.m. No.8714214   🗄️.is đź”—kun

What is an exsome?

 

Research

 

Exosomes from red blood cells contain the transferrin receptor which is absent in mature erythrocytes. Dendritic cell-derived exosomes express MHC I, MHC II, and costimulatory molecules and have been proven to be able to induce and enhance antigen-specific T cell responses in vivo. In addition, the first exosome-based cancer vaccination platforms are being explored in early clinical trials.[25] Exosomes can also be released into urine by the kidneys, and their detection might serve as a diagnostic tool.[26][27][28] Urinary exosomes may be useful as treatment response markers in prostate cancer.[29][30] Exosomes secreted from tumour cells can deliver signals to surrounding cells and have been shown to regulate myofibroblast differentiation.[31] In melanoma, tumor-derived vesicles can enter lymphatics and interact with subcapsular sinus macrophages and B cells in lymph nodes.[32] A recent investigation showed that exosome release positively correlates with the invasiveness of ovarian cancer.[33] Exosomes released from tumors into the blood may also have diagnostic potential. Exosomes are remarkably stable in bodily fluids strengthening their utility as reservoirs for disease biomarkers.[34][35] Patient blood samples stored in biorepositories can be used for biomarker analysis as colorectal cancer cell-derived exosomes spiked into blood plasma could be recovered after 90 days of storage at various temperatures.[36]

 

With neurodegenerative disorders, exosomes appear to play a role in the spread of alpha-synuclein, and are being actively investigated as a tool to both monitor disease progression as well as a potential vehicle for delivery of drug and stem cell based therapy.[39]

 

An online open access database containing genomic information for exosome content has been developed to catalyze research development within the field.[39]

Exosomes and intercellular communication

 

Scientists are actively researching the role that exosomes may play in cell-to-cell signaling, hypothesizing that because exosomes can merge with and release their contents into cells that are distant from their cell of origin (see membrane vesicle trafficking), they may influence processes in the recipient cell.[40] For example, RNA that is shuttled from one cell to another, known as "exosomal shuttle RNA," could potentially affect protein production in the recipient cell.[19][15] By transferring molecules from one cell to another, exosomes from certain cells of the immune system, such as dendritic cells and B cells, may play a functional role in mediating adaptive immune responses to pathogens and tumors.[17][32]

 

Conversely, exosome production and content may be influenced by molecular signals received by the cell of origin. As evidence for this hypothesis, tumor cells exposed to hypoxia secrete exosomes with enhanced angiogenic and metastatic potential, suggesting that tumor cells adapt to a hypoxic microenvironment by secreting exosomes to stimulate angiogenesis or facilitate metastasis to more favorable environment.[23] It has recently been shown that exosomal protein content may change during the progression of chronic lymphocytic leukemia.[41]

 

A study hypothesized that intercellular communication of tumor exosomes could mediate further regions of metastasis for cancer. Hypothetically, exosomes can plant tumor information, such as tainted RNA, into new cells to prepare for cancer to travel to that organ for metastasis. The study found that tumor exosomal communication has the ability to mediate metastasis to different organs. Furthermore, even when tumor cells have a disadvantage for replicating, the information planted at these new regions, organs, can aid in the expansion of organ specific metastasis.[42]

 

Exosomes carry cargo, which can augment innate immune responses. For example, exosomes derived from Salmonella enterica-infected macrophages but not exosomes from uninfected cells stimulate naive macrophages and dendritic cells to secrete pro-inflammatory cytokines such as TNF-α, RANTES, IL-1ra, MIP-2, CXCL1, MCP-1, sICAM-1, GM-CSF, and G-CSF. Proinflammatory effects of exosomes are partially attributed to lipopolysaccharide, which is encapsulated within exosomes.[43]

 

https://en.wikipedia.org/wiki/Exosome_(vesicle)